JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 106 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $472 | -84.3% | 425 | -69.7% | 0.00% | – |
| Q3 2022 | $3,000 | -98.2% | 1,402 | -97.5% | 0.00% | – |
| Q2 2022 | $170,000 | +900.0% | 56,193 | +2128.1% | 0.00% | – |
| Q1 2022 | $17,000 | -79.3% | 2,522 | -74.5% | 0.00% | – |
| Q4 2021 | $82,000 | +74.5% | 9,872 | +55.0% | 0.00% | – |
| Q3 2021 | $47,000 | +46.9% | 6,369 | +36.3% | 0.00% | – |
| Q2 2021 | $32,000 | +52.4% | 4,673 | +132.5% | 0.00% | – |
| Q1 2021 | $21,000 | -32.3% | 2,010 | -54.7% | 0.00% | – |
| Q4 2020 | $31,000 | +342.9% | 4,434 | +434.9% | 0.00% | – |
| Q3 2020 | $7,000 | -66.7% | 829 | -72.5% | 0.00% | – |
| Q2 2020 | $21,000 | -25.0% | 3,013 | -48.5% | 0.00% | – |
| Q1 2020 | $28,000 | -36.4% | 5,847 | +16.4% | 0.00% | – |
| Q4 2019 | $44,000 | +175.0% | 5,022 | +6.0% | 0.00% | – |
| Q3 2019 | $16,000 | -23.8% | 4,736 | +14.6% | 0.00% | – |
| Q2 2019 | $21,000 | -19.2% | 4,132 | -3.1% | 0.00% | – |
| Q1 2019 | $26,000 | +30.0% | 4,266 | -29.6% | 0.00% | – |
| Q4 2018 | $20,000 | -9.1% | 6,060 | +75.0% | 0.00% | – |
| Q3 2018 | $22,000 | -82.9% | 3,463 | -79.5% | 0.00% | – |
| Q2 2018 | $129,000 | -63.1% | 16,868 | +8.0% | 0.00% | – |
| Q1 2018 | $350,000 | +75.0% | 15,624 | -0.3% | 0.00% | – |
| Q4 2017 | $200,000 | +545.2% | 15,675 | +679.9% | 0.00% | – |
| Q3 2017 | $31,000 | +6.9% | 2,010 | -3.5% | 0.00% | – |
| Q2 2017 | $29,000 | -79.3% | 2,082 | -67.3% | 0.00% | – |
| Q1 2017 | $140,000 | – | 6,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |